Anti-IL5 therapies for chronic obstructive pulmonary disease

Donovan, T. and Crossingham, I. and Milan, S.J. and Wang, R. and Bradley, P. (2019) Anti-IL5 therapies for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 2019 (9). ISSN 1469-493X

[thumbnail of Donovan_et_al-2019-Cochrane_Database_of_Systematic_Reviews]

Text (Donovan_et_al-2019-Cochrane_Database_of_Systematic_Reviews)
Donovan_et_al_2019_Cochrane_Database_of_Systematic_Reviews.pdf - Published Version
Available under License Creative Commons Attribution-NonCommercial.
Download (181kB)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of monoclonal antibody therapies targeting IL‐5 signalling (anti‐IL‐5 or anti‐IL‐5Rα) compared with placebo in the treatment of adults with COPD.

Item Type:

Journal Article

Journal or Publication Title:

Cochrane Database of Systematic Reviews

Additional Information:

This is the peer reviewed version of the following article:Donovan T, Crossingham I, Milan SJ, Wang R, Bradley P. Anti‐IL5 therapies for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2019, Issue 9. Art. No.: CD013432. DOI: 10.1002/14651858.CD013432 which has been published in final form at https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013432/full This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

Uncontrolled Keywords:

/dk/atira/pure/subjectarea/asjc/2700/2700

Subjects:

?? general medicinemedicine(all) ??

Departments:

Faculty of Health and Medicine > Medicine
Faculty of Health and Medicine

ID Code:

137754

Deposited By:

ep_importer_pure

Deposited On:

11 Oct 2019 08:35

Refereed?:

Yes

Published?:

Published

Last Modified:

15 Oct 2024 23:16

URI:

https://eprints.lancs.ac.uk/id/eprint/137754